| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0005889> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0009609> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0017106> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0018724> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0035208> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0035209> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0035233> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0206034> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0206035> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0206229> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0282440> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C0282687> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C1175175> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C1443871> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C1704312> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C3489666> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32293717_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Academic Medical Center, University of Amsterdam, Cochrane Work Review Group, Amsterdam, Netherlands, 1105AZ.\', \'University of Eastern Finland, School of Pharmacy, Kuopio, Finland.\', \'University of Bristol, Population Health Sciences, Bristol Medical School, Bristol, UK, BS1 2NT.\', \'University of Tampere, Tampere, Finland.\', \'Galway, Ireland.\', \'Queen\'s University Belfast, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Wellcome-Wolfson Building, 97 Lisburn Road, Belfast, Northern Ireland, UK, BT9 7LB.\', \'Finnish Institute of Occupational Health, TYÖTERVEYSLAITOS, Finland, FI-70032.\', \'Finnish Medicines Agency, Assessment of Pharmacotherapies, Microkatu 1, Kuopio, Finland, FI-70210.\', \'Centers for Disease Control and Prevention (CDC), National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), 626 Cochrans Mill Road, Pittsburgh, PA, USA, 15236.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Blackwood_Bronagh> <https://research.tib.eu/covid-19/entity/Ijaz_Sharea> <https://research.tib.eu/covid-19/entity/Kilinc_Balci_F_Selcen> <https://research.tib.eu/covid-19/entity/Rajamaki_Blair> <https://research.tib.eu/covid-19/entity/Ruotsalainen_Jani_H> <https://research.tib.eu/covid-19/entity/Sauni_Riitta> <https://research.tib.eu/covid-19/entity/Tikka_Christina> <https://research.tib.eu/covid-19/entity/Toomey_Elaine> <https://research.tib.eu/covid-19/entity/Verbeek_Jos_H>
?:doi	10.1002/14651858.CD011621.pub4
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/14651858.CD011621.pub4>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Meta-Analysis> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t> <https://research.tib.eu/covid-19/entity/Systematic_Review>
?:journal	The Cochrane database of systematic reviews
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32293717>
?:pmid	<https://research.tib.eu/covid-19/entity/32293717>
?:pmid	32293717
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C3842553_PROCESS_OF_C0028652> <https://research.tib.eu/covid-19/entity/C3842553_PROCESS_OF_C0679646>
?:title	Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Academic Medical Center, University of Amsterdam, Cochrane Work Review Group, Amsterdam, Netherlands, 1105AZ.\', \'University of Eastern Finland, School of Pharmacy, Kuopio, Finland.\', \'University of Bristol, Population Health Sciences, Bristol Medical School, Bristol, UK, BS1 2NT.\', \'University of Tampere, Tampere, Finland.\', \'Galway, Ireland.\', \'Queen\'s University Belfast, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Wellcome-Wolfson Building, 97 Lisburn Road, Belfast, Northern Ireland, UK, BT9 7LB.\', \'Finnish Institute of Occupational Health, TYÖTERVEYSLAITOS, Finland, FI-70032.\', \'Finnish Medicines Agency, Assessment of Pharmacotherapies, Microkatu 1, Kuopio, Finland, FI-70210.\', \'Centers for Disease Control and Prevention (CDC), National Personal Protective Technology Laboratory (NPPTL), National Institute for Occupational Safety and Health (NIOSH), 626 Cochrans Mill Road, Pittsburgh, PA, USA, 15236.\']

?:citedBy